acute myelogenous leukemia

Showing NaN - NaN of 60

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in

Terminated
  • Acute Myelogenous Leukemia in Relapse
  • +4 more
  • Tucson, Arizona
  • +12 more
Aug 18, 2022

Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

Completed
  • Acute Myelogenous Leukemia
  • Los Angeles, California
  • +32 more
Jun 22, 2022

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +8 more
Apr 5, 2022

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,

Terminated
  • Acute Myelogenous Leukemia
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Mar 17, 2022

Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • XmAb14045
  • Jacksonville, Florida
  • +8 more
Mar 4, 2022

Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • FT-2102 (olutasidenib)
  • +2 more
  • Los Angeles, California
  • +59 more
Mar 2, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (Milademetan, AZA)

Terminated
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Duarte, California
  • +4 more
Sep 14, 2021

Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Worldwide (MCLA-117 bispecific antibody)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Acute Myeloid Leukemia
  • MCLA-117 bispecific antibody
  • Augusta, Georgia
  • +9 more
May 6, 2021

Acute Myelogenous Leukemia Trial in United States (KIR genotype)

Completed
  • Acute Myelogenous Leukemia
  • KIR genotype
  • Scottsdale, Arizona
  • +18 more
Mar 9, 2021

Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,

Terminated
  • Double Cord Blood Transplant
  • +8 more
  • TXA127 300 mcg/kg/day
  • TXA127 1000 mcg/kg/day
  • Houston, Texas
    MD Anderson Cancer Center
Dec 7, 2020

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Infusion of one MPC expanded cord unit and one unexpanded cord unit
  • Infusion of two unexpanded cord blood units.
  • Miami, Florida
  • +8 more
Jun 25, 2020

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Tetanus)

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Tetanus
  • Houston, Texas
  • +1 more
Apr 20, 2020

Acute Myelogenous Leukemia Trial in Houston (Plerixafor, Clofarabine)

Terminated
  • Acute Myelogenous Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 19, 2019

Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in Houston (Decitabine, Valproic Acid)

Completed
  • Myelodysplastic Syndrome
  • Acute Myelogenous Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 2, 2019

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (BVD-523)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Los Angeles, California
  • +4 more
Jan 9, 2019

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Gelonin, Busulfan, Fludarabine)

Terminated
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gelonin
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 30, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Leukemia Trial in Houston (Procrit)

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
May 1, 2018

Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in United States (Standard dose cytarabine for induction, SGN-CD33A,

Completed
  • Acute Myeloid Leukemia
  • Acute Myelogenous Leukemia
  • Standard dose cytarabine for induction
  • +3 more
  • Birmingham, Alabama
  • +12 more
May 8, 2018

Acute Lymphoblastic Leukemia, ALL, Acute Myelogenous Leukemia Trial in Houston (IL-2)

Completed
  • Acute Lymphoblastic Leukemia
  • +9 more
  • IL-2
  • Houston, Texas
  • +1 more
Apr 3, 2018

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, B-cell Chronic Lymphocytic Leukemia Trial in Scottsdale, Atlanta,

Completed
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Nov 16, 2017